Lv4
412 积分 2024-09-24 加入
43RD ANNUAL MEETING OF THE OBESITY SOCIETY AT OBESITYWEEK® Oral Abstracts
10天前
已完结
Poster Abstracts
10天前
已完结
ABSTRACTS FROM THE 43RD ANNUAL MEETING OF THE OBESITY SOCIETY AT OBESITYWEEK® NOVEMBER 4–7, 2025
14天前
已完结
Poster Abstracts
14天前
已完结
Poster Abstracts
14天前
已完结
Acute Cholecystitis
20天前
已完结
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials
1个月前
已完结
One small molecule for man, one giant leap for mankind with obesity
3个月前
已关闭
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
4个月前
已完结
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
